Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
2.910
-0.160 (-5.21%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 06, 2022
Gainers ContraFect (NASDAQ:CFRX) stock in...
Via
Benzinga
Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
↗
January 02, 2022
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the...
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
December 16, 2021
Gainers Eloxx Pharmaceuticals (NASDAQ:
Via
Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
↗
December 16, 2021
Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO...
Via
Benzinga
Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
↗
December 12, 2021
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same...
Via
Talk Markets
Topics
Cannabis
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
↗
December 10, 2021
Texas NORML Director Hired To Oversee State Policy Reform Efforts The National Organization for the Reform of Marijuana Laws (N...
Via
Benzinga
Topics
Cannabis
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
↗
December 01, 2021
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.
Via
Talk Markets
Topics
Cannabis
Enveric Biosciences' CBD-Based Product Reduces Dermatitis Severity In Animal Study
↗
November 18, 2021
Enveric Biosciences (NASDAQ: ENVB) announced data from a preclinical rodent model evaluating EV102, the company's cannabidiol (CBD) based product in...
Via
Benzinga
Earnings Scheduled For November 16, 2021
↗
November 16, 2021
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (...
Via
Benzinga
EXCLUSIVE: Benzinga Interviews Mind Cure CEO Kelsey Ramsden with Updates on Latest Press Release
↗
November 09, 2021
Image by: iStock The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored conte...
Via
Benzinga
Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
↗
October 05, 2021
Photo by Christina Victoria Craft on Unsplash The world is finally waking up to the importance of mental health. It is becoming more acceptable to talk about mental illness....
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
↗
October 18, 2021
The Week In Psychedelics
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
October 05, 2021
Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4...
Via
Benzinga
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
↗
October 01, 2021
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
↗
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference
↗
September 30, 2021
The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 30, 2021
Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The company's market cap stands at $1.4 billion....
Via
Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
↗
September 30, 2021
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on Wednesday. The company, last month, reported Q2...
Via
Benzinga
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
↗
September 20, 2021
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Topics
Cannabis
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
↗
September 20, 2021
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 20, 2021
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....
Via
Benzinga
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
↗
September 17, 2021
The psychedelics sector has closed one of its largest M&As since its inception.
Via
Talk Markets
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
↗
September 17, 2021
The psychedelics sector has closed one of its largest M&As since its inception. On Friday, Enveric Biosciences (NASDAQ:
Via
Benzinga
72 Biggest Movers From Yesterday
↗
September 14, 2021
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...
Via
Benzinga
Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
↗
September 11, 2021
The performance of the psychedelic-focused index components substantially outshone the weed stocks.
Via
Talk Markets
Topics
Cannabis
48 Biggest Movers From Yesterday
↗
September 10, 2021
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy...
Via
Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
↗
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 09, 2021
Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1...
Via
Benzinga
72 Biggest Movers From Yesterday
↗
September 08, 2021
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth....
Via
Benzinga
You Ask, We Analyze: Enveric Biosciences Stock Looks Ready To Skyrocket
↗
September 07, 2021
On Sunday evening, Benzinga asked its followers on Twitter which stocks they’re buying at the open on Monday. From the replies Benzinga selec...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit